Curative Biotechnology Inc Contracts & Agreements

128 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment Number 1 to Patent License Agreement -Exclusive Evaluation Option License dated February 23, 2023 between National Institute of Health and Curative Biotechnology, Inc....
License Agreements
Curative Biotechnology Inc
2024
Amendment Number 2 to Patent License Agreement -Exclusive Evaluation Option License dated November 17, 2023 between National Institute of Health and Curative Biotechnology, Inc....
License Agreements
Curative Biotechnology Inc
2024
Amendment Number 1 to Patent License Agreement dated March 19, 2024 between National Institute of Health and Curative Biotechnology, Inc. (f/k/a Connectyx Technologies Holdings...
License Agreements
Curative Biotechnology Inc
2024
Amended Employment Agreement with Richard Garr dated September 14, 2023
Employment Agreements
Curative Biotechnology Inc
2024
Amended Employment Agreement with Paul Michaels dated September 14, 2023
Employment Agreements
Curative Biotechnology Inc
2024
Amended Employment Agreement with Paul Michaels dated February 28, 2024
Employment Agreements
Curative Biotechnology Inc
2024
Amended Employment Agreement with Barry Ginsberg dated September 14, 2023
Employment Agreements
Curative Biotechnology Inc
2024
Eighth Amendment to March 2022 Convertible Note Transaction Documents
Note Agreements
Curative Biotechnology Inc
2024
Ninth Amendment to March 2022 Convertible Note Transaction Documents
Note Agreements
Curative Biotechnology Inc
2024
Tenth Amendment to March 2022 Convertible Note Transaction Documents
Note Agreements
Curative Biotechnology Inc
2024
Eleventh Amendment to March 2022 Convertible Note Transaction Documents
Note Agreements
Curative Biotechnology Inc
2024
Twelfth Amendment to March 2022 Convertible Note Transaction Documents
Note Agreements
Curative Biotechnology Inc
2024
Thirteenth Amendment to March 2022 Convertible Note Transaction Documents
Note Agreements
Curative Biotechnology Inc
2024
Fourteenth Amendment to March 2022 Convertible Note Transaction Documents
Note Agreements
Curative Biotechnology Inc
2024
Fifteenth Amendment to March 2022 Convertible Note Transaction Documents
Note Agreements
Curative Biotechnology Inc
2024
Sixteenth Amendment to March 2022 Convertible Note Transaction Documents
Note Agreements
Curative Biotechnology Inc
2024
Seventeenth Amendment to March 2022 Convertible Note Transaction Documents
Note Agreements
Curative Biotechnology Inc
2024
Seventh Amendment to March 2022 Convertible Note Transaction Documents
Note Agreements
Curative Biotechnology Inc
2023
Seventh Amendment to March 2022 Convertible Note Transaction Documents
Note Agreements
Curative Biotechnology Inc
Biotechnology
2023
Sixth Amendment to March 2022 Convertible Note Transaction Documents
Note Agreements
Curative Biotechnology Inc
2023
Second Amendment to March 2022 Convertible Note Transaction Documents
Note Agreements
Curative Biotechnology Inc
Biotechnology
2022
Third Amendment to March 2022 Convertible Note Transaction Documents
Note Agreements
Curative Biotechnology Inc
Biotechnology
2022
Fourth Amendment to March 2022 Convertible Note Transaction Documents
Note Agreements
Curative Biotechnology Inc
2022
Fifth Amendment to March 2022 Convertible Note Transaction Documents
Note Agreements
Curative Biotechnology Inc
2022
Form of Underwriting Agreement
Underwriting Agreements
Curative Biotechnology Inc
Biotechnology
NY
2022
Specimen of Common Stock Certificate
Stock Agreements
Curative Biotechnology Inc
2022
Specimen Series A Preferred Stock
Stock Agreements
Curative Biotechnology Inc
2022
Specimen of Series B Preferred Stock
Stock Agreements
Curative Biotechnology Inc
Biotechnology
2022
Specimen of Series C Preferred Stock
Stock Agreements
Curative Biotechnology Inc
Biotechnology
2022
Form of Common Stock Purchase Warrant issued to Certain Consultants in May 2021
Warrant Agreements
Curative Biotechnology Inc
2022
Form of Common Stock Purchase Warrant issued to Investors in August 2021
Warrant Agreements
Curative Biotechnology Inc
2022
Form of Warrant issued to investors on May 21, 2021
Warrant Agreements
Curative Biotechnology Inc
Biotechnology
2022
Form of Warrant issued to Investors in Note Offering from November 2020 through January 2021
Warrant Agreements
Curative Biotechnology Inc
Biotechnology
NY
2022
Form of Common Stock Purchase warrant issued to Consultant on December 3, 2020
Warrant Agreements
Curative Biotechnology Inc
2022
Form of Consultant Warrants issued between December 2020 and January 2021
Curative Biotechnology Inc
2022
Form of Common Stock Purchase Warrant issued to Paul Michaels on June 11, 2021
Warrant Agreements
Curative Biotechnology Inc
Biotechnology
2022
Form of Common Stock Purchase Warrant issued to Marc Drimer on July 14, 2021
Warrant Agreements
Curative Biotechnology Inc
Biotechnology
FL
2022
Form of Common Stock Purchase Option issued to Catherine Sohn pursuant to Consulting Agreement dated September 27, 2021
Stock Agreements
Curative Biotechnology Inc
Biotechnology
FL
2022
2021 Equity Incentive Plan
Bonus & Incentive Agreements
Curative Biotechnology Inc
2022
Form of Stock Option Grant for 2021 Equity Incentive Plan
Bonus & Incentive Agreements
Curative Biotechnology Inc
2022
Form of Restricted Stock Award Agreement for 2021 Equity Incentive Plan
Bonus & Incentive Agreements
Curative Biotechnology Inc
Biotechnology
FL
2022
Form of Restricted Stock Unit Agreement for 2021 Equity Incentive Plan
Bonus & Incentive Agreements
Curative Biotechnology Inc
Biotechnology
FL
2022
Form of Underwriter Warrant
Warrant Agreements
Curative Biotechnology Inc
2022
Form of warrant to be issued in Underwritten Offering
Warrant Agreements
Curative Biotechnology Inc
2022
Form of Subscription Agreement for Investor Offerings in August 2021
Subscription Agreements
Curative Biotechnology Inc
Biotechnology
2022
Form of Subscription Agreement for Investor Offerings on May 21, 2021
Subscription Agreements
Curative Biotechnology Inc
Biotechnology
2022
Form of Note Issued to Investors between November 2020 and January 2021
Note Agreements
Curative Biotechnology Inc
2022
Settlement Agreement dated August 9, 2021
Settlement Agreements
Curative Biotechnology Inc
Biotechnology
2022
Consulting Agreement dated September 27, 2021
Consulting Agreements
Curative Biotechnology Inc
Biotechnology
DE
2022
Employment Agreement with Richard Garr dated October 1, 2020
Employment Agreements
Curative Biotechnology Inc
2022
Employment Agreement with Barry Ginsberg dated October 1, 2020
Employment Agreements
Curative Biotechnology Inc
Biotechnology
2022
Employment Agreement with Paul Michaels dated October 1, 2020
Employment Agreements
Curative Biotechnology Inc
2022
License, Funding and Operational Agreement dated October 1, 2021 between Curative Biotechnology, Inc., David Horn, LLC, and Mid-Atlantic BioTherapeutics, Inc
License Agreements
Curative Biotechnology Inc
Biotechnology
PA
2022
Exclusive Option Agreement for Purchase of Patent Rights dated September 30, 2020 between Curative Biotechnology (fka Connectyx Technologies Holdings Group) and IEM Inc
Purchase Agreements
Curative Biotechnology Inc
Biotechnology
2022
Patent License Agreement dated February 2, 2021 between National Institute of Health and Curative Biotechnology, Inc. (fka Connectyx Technologies Holdings Group)
License Agreements
Curative Biotechnology Inc
2022
Patent License Agreement -Exclusive Evaluation Option License dated October 15, 2020 between National Institute of Health and Curative Biotechnology, Inc. (fka Connectyx...
License Agreements
Curative Biotechnology Inc
Biotechnology
2022
License, Funding and Operational Agreement dated September 30, 2020 between Mid-Atlantic BioTherapeutics, Inc., David Horn, LLC, and Curative Biotechnology, Inc. (fka Connectyx...
License Agreements
Curative Biotechnology Inc
Biotechnology
FL
2022
First Amendment to License, Funding and Operational Agreement dated December 30, 2021 between Mid-Atlantic BioTherapeutics and Curative Biotechnology, Inc
License Agreements
Curative Biotechnology Inc
2022
First Amendment to License, Funding and Operational Agreement dated December 31, 2021 between Mid-Atlantic BioTherapeutics, Inc. and Curative Biotechnology, Inc
License Agreements
Curative Biotechnology Inc
2022
Securities Purchase Agreement for March 2022 Offering
Purchase Agreements
Curative Biotechnology Inc
Biotechnology
NY
2022
Secured Convertible Promissory Note for March 2022 Offering
Note Agreements
Curative Biotechnology Inc
Biotechnology
NY
2022
Security Agreement for March 2022 Offering
Security Agreements
Curative Biotechnology Inc
2022
Intellectual Property Security Agreement for March 2022 Offering
Security Agreements
Curative Biotechnology Inc
2022
Warrant for March 2022 Offering
Warrant Agreements
Curative Biotechnology Inc
Biotechnology
2022
Form of Lock Up Agreement for March 2022 Offering
Curative Biotechnology Inc
Biotechnology
2022
Cooperative Research and Development Agreement for Intramura-PhS Clinical Research
Development Agreements
Curative Biotechnology Inc
2022
Amendment to March 2022 Convertible Note Transaction Documents
Note Agreements
Curative Biotechnology Inc
2022
Form of Warrant Agency Agreement
Warrant Agreements
Curative Biotechnology Inc
2022
Form of Common Stock Purchase Option issued to Catherine Sohn pursuant to Consulting Agreement dated September 27, 2021
Stock Agreements
Curative Biotechnology Inc
Biotechnology
FL
2022
Form of Underwriter Agreement
Curative Biotechnology Inc
Biotechnology
NY
2022
Settlement Agreement dated August 9, 2021
Settlement Agreements
Curative Biotechnology Inc
Biotechnology
2022
Consulting Agreement dated September 27, 2021
Consulting Agreements
Curative Biotechnology Inc
2022
License, Funding and Operational Agreement dated October 1, 2021 between Curative Biotechnology, Inc., David Horn, LLC, and Mid-Atlantic BioTherapeutics, Inc
License Agreements
Curative Biotechnology Inc
Biotechnology
PA
2022
Patent License Agreement -Exclusive Evaluation Option License dated October 15, 2020 between National Institute of Health and Curative Biotechnology, Inc. (fka Connectyx...
License Agreements
Curative Biotechnology Inc
Biotechnology
2022
License, Funding and Operational Agreement dated September 30, 2020 between Mid-Atlantic BioTherapeutics, Inc., David Horn, LLC, and Curative Biotechnology, Inc. (fka Connectyx...
License Agreements
Curative Biotechnology Inc
Biotechnology
FL
2022
First Amendment to License, Funding and Operational Agreement dated December 30, 2021 between Mid-Atlantic BioTherapeutics and Curative Biotechnology, Inc
License Agreements
Curative Biotechnology Inc
2022
First Amendment to License, Funding and Operational Agreement dated December 31, 2021 between Mid-Atlantic BioTherapeutics, Inc. and Curative Biotechnology, Inc
License Agreements
Curative Biotechnology Inc
2022
Securities Purchase Agreement for March 2022 Offering
Purchase Agreements
Curative Biotechnology Inc
Biotechnology
NY
2022
Secured Convertible Promissory Note for March 2022 Offering
Note Agreements
Curative Biotechnology Inc
Biotechnology
NY
2022
Security Agreement for March 2022 Offering
Security Agreements
Curative Biotechnology Inc
2022
Intellectual Property Security Agreement for March 2022 Offering
Security Agreements
Curative Biotechnology Inc
Biotechnology
NY
2022
Warrant for March 2022 Offering
Warrant Agreements
Curative Biotechnology Inc
Biotechnology
2022
Form of Lock Up Agreement for March 2022 Offering
Curative Biotechnology Inc
Biotechnology
2022
Amendment to March 2022 Convertible Note Transaction Documents
Note Agreements
Curative Biotechnology Inc
2022
Amendment to March 2022 Convertible Note Transaction Documents
Note Agreements
Curative Biotechnology Inc
Biotechnology
2022
Underwriter Agreement
Curative Biotechnology Inc
2022
Form of Common Stock Purchase Warrant issued in Aegis Capital Underwritten Offering
Warrant Agreements
Curative Biotechnology Inc
2022
Form of Warrant Agent Agreement between Curative Biotechnology and Issuer Direct Corporation
Warrant Agreements
Curative Biotechnology Inc
Biotechnology
2022
Form of Underwriter Warrant
Warrant Agreements
Curative Biotechnology Inc
Biotechnology
NY
2022
Cooperative Research and Development Agreement for Intramura-PhS Clinical Research
Development Agreements
Curative Biotechnology Inc
Biotechnology
2022
Specimen of Common Stock Certificate
Stock Agreements
Curative Biotechnology Inc
2022
Specimen Series A Preferred Stock
Stock Agreements
Curative Biotechnology Inc
Biotechnology
2022
Specimen of Series B Preferred Stock
Stock Agreements
Curative Biotechnology Inc
Biotechnology
2022
Specimen of Series C Preferred Stock
Stock Agreements
Curative Biotechnology Inc
2022
Form of Common Stock Purchase Warrant issued to Certain Consultants in May 2021
Warrant Agreements
Curative Biotechnology Inc
2022
Form of Common Stock Purchase Warrant issued to Investors in August 2021
Warrant Agreements
Curative Biotechnology Inc
Biotechnology
FL
2022
Form of Warrant issued to investors on May 21, 2021
Warrant Agreements
Curative Biotechnology Inc
Biotechnology
2022
Form of Warrant issued to Investors in Note Offering from November 2020 through January 2021
Warrant Agreements
Curative Biotechnology Inc
2022
Form of Common Stock Purchase warrant issued to Consultant on December 3, 2020
Warrant Agreements
Curative Biotechnology Inc
2022
Form of Consultant Warrants issued between December 2020 and January 2021
Curative Biotechnology Inc
Biotechnology
NY
2022
Form of Common Stock Purchase Warrant issued to Paul Michaels on June 11, 2021
Warrant Agreements
Curative Biotechnology Inc
Biotechnology
2022
Form of Common Stock Purchase Warrant issued to Marc Drimer on July 14, 2021
Warrant Agreements
Curative Biotechnology Inc
2022
2021 Equity Incentive Plan
Bonus & Incentive Agreements
Curative Biotechnology Inc
2022
Form of Stock Option Grant for 2021 Equity Incentive Plan
Bonus & Incentive Agreements
Curative Biotechnology Inc
Biotechnology
FL
2022
Form of Restricted Stock Award Agreement for 2021 Equity Incentive Plan
Bonus & Incentive Agreements
Curative Biotechnology Inc
Biotechnology
FL
2022
Form of Restricted Stock Unit Agreement for 2021 Equity Incentive Plan
Bonus & Incentive Agreements
Curative Biotechnology Inc
2022
Form of Subscription Agreement for Investor Offerings in August 2021
Subscription Agreements
Curative Biotechnology Inc
2022
Form of Subscription Agreement for Investor Offerings on May 21, 2021
Subscription Agreements
Curative Biotechnology Inc
Biotechnology
2022
Form of Note Issued to Investors between November 2020 and January 2021
Note Agreements
Curative Biotechnology Inc
2022
Settlement Agreement dated August 9, 2021
Settlement Agreements
Curative Biotechnology Inc
Biotechnology
2022
Consulting Agreement dated September 27, 2021
Consulting Agreements
Curative Biotechnology Inc
Biotechnology
DE
2022
Employment Agreement with Richard Garr dated October 1, 2020
Employment Agreements
Curative Biotechnology Inc
2022
Employment Agreement with Barry Ginsberg dated October 1, 2020
Employment Agreements
Curative Biotechnology Inc
Biotechnology
2022
Employment Agreement with Paul Michaels dated October 1, 2020
Employment Agreements
Curative Biotechnology Inc
Biotechnology
2022
License, Funding and Operational Agreement dated October 1, 2021 between Curative Biotechnology, Inc., David Horn, LLC, and Mid-Atlantic BioTherapeutics, Inc
License Agreements
Curative Biotechnology Inc
Biotechnology
PA
2022
Exclusive Option Agreement for Purchase of Patent Rights dated September 30, 2020 between Curative Biotechnology (fka Connectyx Technologies Holdings Group) and IEM Inc
Purchase Agreements
Curative Biotechnology Inc
Biotechnology
2022
Patent License Agreement dated February 2, 2021 between National Institute of Health and Curative Biotechnology, Inc. (fka Connectyx Technologies Holdings Group)
License Agreements
Curative Biotechnology Inc
Biotechnology
2022
Patent License Agreement -Exclusive Evaluation Option License dated October 15, 2020 between National Institute of Health and Curative Biotechnology, Inc. (fka Connectyx...
License Agreements
Curative Biotechnology Inc
2022
License, Funding and Operational Agreement dated September 30, 2020 between Mid-Atlantic BioTherapeutics, Inc., David Horn, LLC, and Curative Biotechnology, Inc. (fka Connectyx...
License Agreements
Curative Biotechnology Inc
Biotechnology
FL
2022
First Amendment to License, Funding and Operational Agreement dated December 30, 2021 between Mid-Atlantic BioTherapeutics and Curative Biotechnology, Inc
License Agreements
Curative Biotechnology Inc
2022
First Amendment to License, Funding and Operational Agreement dated December 31, 2021 between Mid-Atlantic BioTherapeutics, Inc. and Curative Biotechnology, Inc
License Agreements
Curative Biotechnology Inc
2022
Form of Securities Purchase Agreement for March 2022 Offering
Purchase Agreements
Curative Biotechnology Inc
Biotechnology
NY
2022
Form of Secured Convertible Promissory Note for March 2022 Offering
Note Agreements
Curative Biotechnology Inc
Biotechnology
NY
2022
Form of Security Agreement for March 2022 Offering
Security Agreements
Curative Biotechnology Inc
2022
Form of Intellectual Property Security Agreement for March 2022 Offering
Security Agreements
Curative Biotechnology Inc
Biotechnology
NY
2022
Form of Warrant for March 2022 Offering
Warrant Agreements
Curative Biotechnology Inc
Biotechnology
2022
Form of Lock Up Agreement for March 2022 Offering
Curative Biotechnology Inc
2022
Cooperative Research and Development Agreement for Intramura-PhS Clinical Research
Development Agreements
Curative Biotechnology Inc
2022